归创通桥医疗科技股份有限公司（股票代码：02190）于2026年7月6日发布公告，公司在香港联交所场内回购H股普通股17,500股，占该次股份回购前公司已发行股本约0.0053%。每股回购价格为19.52港元，合计耗资341,600港元（折合约34.16万港元）。
本次回购前，公司已发行股份总数为323,975,113股，库藏股数为12,375,631股。本次回购后，公司最新已发行股份数为323,957,613股，库藏股数增至12,393,131股。公司于2026年5月13日通过回购授权，授权回购数量为32,715,311股，截至目前已回购股份合计3,246,500股，约占授权当日已发行股份总数的0.9693%。公告同时披露，公司在本次回购后，将自回购之日起的30日内暂不会进一步发行新股或出售、转让库藏股，即本次回购的暂止期截至2026年8月5日。
公司确认已依据香港联合交易所有限公司证券上市规则及相关法律法规办理本次回购。
本公告由董事赵中签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.